BodyScan 2

Announcing the first science-backed longevity station, unveiled at CES 2026.

1 scan. 60 biomarkers.

BodyScan 2 is the next generation of Withings scales, designed to turn 60 biomarkers into a single, clear picture of your long-term health. The goal was to show the power of that data simplified in the app to help users actively improve their longevity, not just track their weight.

BodyScan 2 scale with embedded interface displaying Heart Age

An embedded interface that speaks up

The onboard display surfaces what matters in the moment: guiding you through the scan, then cycling through cardiovascular alerts, metabolic insights, and daily check-ins right on the device, before you even open the app.

Embedded interface strip cycling through cardiovascular, metabolic, and daily insight screens

Designed with Clément Parfait and Victor Coulet.

A dedicated Health tab

We created a new Health tab centered on a single Health Trajectory: one clear read on whether you're gaining or losing healthy years, driven by your biggest contributing factors. From there, everything simplifies down into two scores — Cardiovascular and Metabolic Health — so progress is always easy to read at a glance.

Health tab showing Greater Longevity trajectory with cardiovascular and metabolic scores

Designed with Victor Coulet.

Cardiovascular Health

Heart Age and Vascular Age roll up into one score, tracking efficiency, responsiveness, and arterial stiffness over time so users can see cardiovascular improvement in years gained, not just numbers.

Cardiovascular Health score card showing Heart Age and Vascular Age improvements

Metabolic Health

Glycemic Impact and Metabolic Profile combine nerve response, visceral fat, and muscle/fat ratio into a single trend, making insulin sensitivity and body composition changes easy to follow month over month.

Metabolic Health score card showing Glycemic Impact and Metabolic Profile

Every score, one tap deeper

Each score expands into its own detail view: weekly trend, contributing factors, and guidance validated against the underlying biomarkers, so the simplified score never feels like a black box.

From CES prototype to production

This target vision started as a prototype shown on stage at CES 2026. Variations of it are now being pushed to production, with continued work and iteration led by Victor Coulet.

Withings Body Scan 2 booth at CES, the first science-backed longevity station